Publications

HRA Pharma has collaborated on a number of scientific publications in the areas of women’s health and endocrinology – whether through scientific cooperation or sponsorship.

filter by theme
Women's health
Endocrinology
Academic support
Non clinical
 contact us

Publications

HRA Pharma has collaborated on a number of scientific publications in the areas of women’s health and endocrinology – whether through scientific cooperation or sponsorship.

Lack of long-lasting effects of mitotane adjuvant therapy in a mouse xenograft model of adrenocortical carcinoma.
Doghman M, Lalli E. Mol Cell Endocrinol. 2013 Dec 5;381(1-2):66-9.
Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells.
Hescot S, Slama A, Lombès A, Paci A, Remy H, Leboulleux S, Chadarevian R, Trabado S, Amazit L, Young J, Baudin E, Lombès M. Endocr Relat Cancer. 2013 May 21;20(3):371-81.
No evidence for relevant QT interval prolongation in mitotane-treated patients with adrenocortical carcinoma.
Ederhy S, Cohen A, Dufaitre G, Chaderevian R, Abbas H, Bertagna X, Libé R. J Endocrinol Invest. 2012 Nov;35(10):911-4.
Combination chemotherapy in advanced adrenocortical carcinoma.
Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabar
Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study.
Hermsen IG, Fassnacht M, Terzolo M, Houterman S, den Hartigh J, Leboulleux S, Daffara F, Berruti A, Chadarevian R, Schlumberger M, Allolio B, Haak HR, Baudin E. J Clin Endocrinol Metab. 2011 Jun;96(6):1844-5.
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?